Circulating proteomic signature for detection of biomarkers in bladder cancer patients

The identification of clinically-relevant early diagnostic and prognostic protein biomarkers is essential to maximize therapeutic efficacy and prevent cancer progression. The aim of the current study is to determine whether aberrant plasma protein profile can be applied as a surrogate tool for early...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedjadi, Taoufik, Benabdelkamal, Hicham, Albarakati, Nada, Masood, Afshan, Al-Sayyad, Ahmed, Alfadda, Assim A., Alanazi, Ibrahim O., Al-Ammari, Adel, Al-Maghrabi, Jaudah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335182/
https://www.ncbi.nlm.nih.gov/pubmed/32620920
http://dx.doi.org/10.1038/s41598-020-67929-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335182/
https://www.ncbi.nlm.nih.gov/pubmed/32620920
http://dx.doi.org/10.1038/s41598-020-67929-z

Ejemplares similares